Benzinga | Feb 17, 2021 07:00AM EST

Wedbush Maintains Outperform on DocuSign, Raises Price Target to $300

Wedbush analyst Daniel Ives maintains DocuSign (NASDAQ:DOCU) with a Outperform and raises the price target from $270 to $300.